ING Groep NV Acquires Shares of 141,000 Hinge Health Inc. $HNGE

ING Groep NV bought a new position in shares of Hinge Health Inc. (NYSE:HNGE) during the fourth quarter, Holdings Channel reports. The firm bought 141,000 shares of the company’s stock, valued at approximately $6,549,000.

A number of other hedge funds also recently made changes to their positions in HNGE. First Horizon Corp raised its stake in shares of Hinge Health by 163.9% during the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares during the period. High Point Wealth Management LLC bought a new stake in shares of Hinge Health during the 4th quarter worth $46,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Hinge Health during the 3rd quarter worth $49,000. Jones Financial Companies Lllp raised its stake in shares of Hinge Health by 348.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after purchasing an additional 870 shares during the period. Finally, US Bancorp DE raised its stake in shares of Hinge Health by 96.1% during the 3rd quarter. US Bancorp DE now owns 3,110 shares of the company’s stock worth $153,000 after purchasing an additional 1,524 shares during the period.

Analysts Set New Price Targets

HNGE has been the topic of a number of recent analyst reports. Piper Sandler reiterated an “overweight” rating and set a $95.00 target price on shares of Hinge Health in a research note on Wednesday, May 6th. Citizens Jmp lifted their target price on Hinge Health from $65.00 to $80.00 and gave the stock a “market outperform” rating in a research note on Wednesday, May 6th. Barclays lifted their price objective on Hinge Health from $52.00 to $62.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Wall Street Zen cut Hinge Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Finally, Stifel Nicolaus boosted their price objective on Hinge Health from $59.00 to $67.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $67.53.

Hinge Health Stock Performance

Shares of Hinge Health stock opened at $63.00 on Tuesday. Hinge Health Inc. has a 52-week low of $30.08 and a 52-week high of $66.55. The stock’s 50-day simple moving average is $48.38 and its 200 day simple moving average is $45.50. The stock has a market capitalization of $4.88 billion and a P/E ratio of -5.11.

Hinge Health (NYSE:HNGE) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. The business had revenue of $182.31 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The company’s revenue was up 47.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.30 earnings per share. Equities research analysts forecast that Hinge Health Inc. will post 1.21 EPS for the current fiscal year.

Insider Buying and Selling at Hinge Health

In other Hinge Health news, Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of Hinge Health stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $60.22, for a total transaction of $5,018,373.48. Following the completion of the transaction, the chairman owned 83,334 shares of the company’s stock, valued at $5,018,373.48. The trade was a 50.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Antonio Perez sold 104,544 shares of the business’s stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $55.09, for a total value of $5,759,328.96. Following the transaction, the chief executive officer directly owned 35,470 shares of the company’s stock, valued at $1,954,042.30. The trade was a 74.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 554,600 shares of company stock valued at $29,859,068 in the last quarter. 18.92% of the stock is currently owned by corporate insiders.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.